Watch CBS News

FDA's advisory committee backs Merck's COVID-19 antiviral pill

The U.S. may soon be implementing new testing requirements for travelers entering the U.S. amid growing concerns over the new COVID Omicron variant. This week a panel of FDA advisers voted to endorse Merck’s COVID-19 antiviral pill for high-risk individuals. Infectious diseases physician at Brigham and Women's Hospital and chair of that FDA panel, Dr. Lindsey Baden, joins CBSN AM to discuss.
View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.